Results 1 to 10 of about 196,807 (276)

Decreasing Particle Size of Paclitaxel Using Polymer in Fractional Precipitation Process [PDF]

, 2016
Min-Jae Kim, Jin‐Hyun Kim
openalex   +1 more source

ĐÁNH GIÁ KẾT QUẢ SỐNG THÊM VÀ MỘT SỐ YẾU TỐ LIÊN QUAN CỦA PHÁC ĐỒ PACLITAXEL TRONG UNG THƯ VÚ TÁI PHÁT DI CĂN

, 2023
Thanh Đức Lê, Thị Dịu Phạm
openalex   +2 more sources

Ovariectomy increases paclitaxel-induced mechanical hypersensitivity and reduces anti-inflammatory CD4+ T cells in the dorsal root ganglion of female mice [PDF]

, 2022
Diana Goode, Neal E. Mecum
openalex   +1 more source

Comparison of nab-paclitaxel, paclitaxel, and oxaliplatin-induced peripheral neuro­pathy: a cross-sectional cohort study

Acta Oncologica
Background and purpose: There remains limited evidence regarding the relative neurotoxic potential of nab-paclitaxel long-term. This cross-sectional matched cohort study aimed to compare the severity and natural history of chemotherapy-induced peripheral
Terry Trinh, Kimberley Au, Arun V. Krishnan, Hannah C. Timmins, Tiffany Li, Peter Grimison, David Goldstein, Susanna B. Park   +7 more
doaj   +1 more source

Pharmacokinetic evaluation of paclitaxel, albumin-binding paclitaxel, and liposomal-encapsulated albumin-binding paclitaxel upon gastric subserosal administration

Frontiers in Pharmacology
Introduction: Systemic chemotherapy is typically administered following radical gastrectomy for advanced stage. To attenuate systemic side effects, we evaluated the effectiveness of regional chemotherapy using paclitaxel, albumin-paclitaxel, and liposome-
Yoontaek Lee, Sun Mi Park, In Ho Song, Bom Sahn Kim, Hyun Soo Park, Hyun Soo Park, Hyun Soo Park, Byung Seok Moon, Hyung-Ho Kim   +8 more
doaj   +1 more source

Supplementary Data from Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer

, 2023
Kim Blenman, Michał Marczyk, Thomas Karn, Qing Tao, Xiaotong Li, Vignesh Gunasekharan, Vesal Yaghoobi, Yalai Bai, Eiman Ibrahim, Tristen Park, Andrea Silber, Denise M. Wolf, Emily Reisenbichler, Carsten Denkert, Bruno V. Sinn, Mariya Rozenblit, Julia Foldi, David L. Rimm, Sibylle Loibl, Lajos Pusztai   +19 more
openalex   +1 more source

Phase I study of vinorelbine and paclitaxel by 3‐hour simultaneous infusion with and without granulocyte colony‐stimulating factor support in metastatic breast carcinoma [PDF]

, 2001
Nuhad K. Ibrahim, Aman U. Buzdar, Vicente Valero, Kapil Dhingra, Jie Willey, Gabriel N. Hortobágyi   +5 more
openalex   +1 more source

Supplementary Data from Translocon-associated Protein Subunit SSR3 Determines and Predicts Susceptibility to Paclitaxel in Breast Cancer and Glioblastoma

, 2023
Crismita Dmello, Aarón Sonabend, Víctor A. Arrieta, Daniel Y. Zhang, Deepak Kanojia, Li Chen, Andrew Gould, Jiangshan Zhang, Seong Jae Kang, Jan Winter, Craig Horbinski, Christina Amidei, Balázs Győrffy, Álex Cordero, Catalina Lee-Chang, Brandyn Castro, Patrick D. Hsu, Atique U. Ahmed, Maciej S. Lesniak, Roger Stupp, Adam M. Sonabend   +20 more
openalex   +1 more source

Supplementary Table 2 from Regulatory Polymorphisms in β-Tubulin IIa Are Associated with Paclitaxel-Induced Peripheral Neuropathy

, 2023
Luis J. Leandro‐García, Susanna Leskelä, Carlos A. Jara, Henrik Gréen, Elisabeth Åvall‐Lundqvist, Heather E. Wheeler, M. Eileen Dolan, Lucía Inglada‐Pérez, Agnieszka Maliszewska, Aguirre A. de Cubas, Iñaki Comino‐Méndez, Veronika Mančíková, Alberto Cascón, Mercedes Robledo, Cristina Rodríguez‐Antona   +14 more
openalex   +1 more source

Comparison of the Clinical Effects of Paclitaxel and Paclitaxel plus Oxaliplatin as the Second-line Treatment of Advanced Non-small Cell Lung Cancer

Chinese Journal of Lung Cancer, 2009
Background and objective Second-line chemotherapy with taxanes for the patients with non-small cell lung cancer (NSCLC), who had disease recurrence or failure in previously treated with platinum-based chemotherapy, has been shown to be effective. Besides
Tianqing CHU, Hao LIN, Jie SHEN, Runbo ZHONG, Baohui HAN   +4 more
doaj